What are new opportunities for clinical practice the VERIFY study opens and which values for native diabetes patients? Joint conclusion on the advisory board results. November 6, 2019

What are new opportunities for clinical practice the VERIFY study opens and which values for native diabetes patients? Joint conclusion on the advisory board results. November 6, 2019

According to key diabetic studies, the early use of metformin glucose lowering therapy is associated with a reduced risk of developing micro- and, in the long term, 10-year follow-up, macrovascular complications and cardiovascular mortality. Short-term studies results on combined glucose lowering th...

Full description

Saved in:
Bibliographic Details
Main Authors: Marina V. Shestakova, Mikhail B. Antsiferov, Alexander S. Ametov, Gagik R. Galstyan, Tatiana Y. Demidova, Alexey V. Zilov, Tatiana N. Markova, Nina A. Petunina, Natalya A. Chernikova, Minara S. Shamkhalova
Format: article
Language:EN
RU
Published: Endocrinology Research Centre 2020
Subjects:
diabetes mellitus
vildagliptin
metformin
hba1c
new onset diabetes mellitus
Nutritional diseases. Deficiency diseases
RC620-627
Online Access:https://doaj.org/article/ce89e3c8673e4cb8b05e23404c86d100
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://doaj.org/article/ce89e3c8673e4cb8b05e23404c86d100

Similar Items